Cargando…
Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
Background: Immunotherapy has been a promising approach option for lung cancer. Method: All the open-accessed data was obtained from the Cancer Genome Atlas (TCGA) database. All the analysis was conducted using the R software analysis. Results: Firstly, the genes differentially expressed in lung can...
Autores principales: | Zhan, Xue, Feng, Shihan, Zhou, Xutao, Liao, Wei, Zhao, Bin, Yang, Qian, Tan, Qi, Shen, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640754/ https://www.ncbi.nlm.nih.gov/pubmed/36386793 http://dx.doi.org/10.3389/fgene.2022.1047435 |
Ejemplares similares
-
Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy
por: Wang, Jinsong, et al.
Publicado: (2023) -
Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022) -
Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022) -
Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022) -
Prognostic necroptosis-related gene signature aids immunotherapy in lung adenocarcinoma
por: Song, Yuqi, et al.
Publicado: (2022)